The Department of Health and Human Services is endorsing self-collected vaginal samples for cervical cancer screening and requiring most private insurance plans to cover testing without cost sharing.

The FDA recently cleared another option for at-home self-collection for cervical cancer screening, further broadening access.

The U.S. Health Resources and Services Administration (HRSA) has updated cervical cancer screening guidelines to allow women aged 30–65 at average risk to self-collect samples for high-risk HPV ...

—Women who participated in screening via self-collection of samples for HPV testing had higher screening rates compared to patients who only received telephone reminders, demonstrating the potential ...

Mail-in self-collection tests for human papillomavirus (HPV) more than doubled cervical cancer screening participation among never- and under-screened U.S. women, according to a first-of-its-kind ...

Please provide your email address to receive an email when new articles are posted on . The rise of patients collecting their own samples for diagnostic tests seems poised to change how we approach ...

Cervical cancer kills 4,300 American women annually. Most of these deaths are preventable. Teal Health's at-home screening ...

MILFORD, Mass., April 8, 2026 /PRNewswire/ -- Waters Corporation (WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV Self-Collection Kit and approved ...

A self-collection (SC) device that could easily be used at home proved safe and accurate for cervical screening in the SELF-CERV prospective nonrandomized clinical trial, as reported in JAMA Network ...